121 related articles for article (PubMed ID: 26648031)
1. Semaphorin 4A enhances lung fibrosis through activation of Akt via PlexinD1 receptor.
Peng HY; Gao W; Chong FR; Liu HY; Zhang JI
J Biosci; 2015 Dec; 40(5):855-62. PubMed ID: 26648031
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts.
Shi-Wen X; Chen Y; Denton CP; Eastwood M; Renzoni EA; Bou-Gharios G; Pearson JD; Dashwood M; du Bois RM; Black CM; Leask A; Abraham DJ
Mol Biol Cell; 2004 Jun; 15(6):2707-19. PubMed ID: 15047866
[TBL] [Abstract][Full Text] [Related]
3. Induction of Inflammation and Fibrosis by Semaphorin 4A in Systemic Sclerosis.
Carvalheiro T; Affandi AJ; Malvar-Fernández B; Dullemond I; Cossu M; Ottria A; Mertens JS; Giovannone B; Bonte-Mineur F; Kok MR; Marut W; Reedquist KA; Radstake TR; García S
Arthritis Rheumatol; 2019 Oct; 71(10):1711-1722. PubMed ID: 31012544
[TBL] [Abstract][Full Text] [Related]
4. Expression of Semaphorin 4A and its potential role in rheumatoid arthritis.
Wang L; Song G; Zheng Y; Tan W; Pan J; Zhao Y; Chang X
Arthritis Res Ther; 2015 Aug; 17(1):227. PubMed ID: 26303122
[TBL] [Abstract][Full Text] [Related]
5. Expression of neuroimmune semaphorins 4A and 4D and their receptors in the lung is enhanced by allergen and vascular endothelial growth factor.
Smith EP; Shanks K; Lipsky MM; DeTolla LJ; Keegan AD; Chapoval SP
BMC Immunol; 2011 May; 12():30. PubMed ID: 21595947
[TBL] [Abstract][Full Text] [Related]
6. Rac inhibition reverses the phenotype of fibrotic fibroblasts.
Xu SW; Liu S; Eastwood M; Sonnylal S; Denton CP; Abraham DJ; Leask A
PLoS One; 2009 Oct; 4(10):e7438. PubMed ID: 19823586
[TBL] [Abstract][Full Text] [Related]
7. Semaphorin 4A exerts a proangiogenic effect by enhancing vascular endothelial growth factor-A expression in macrophages.
Meda C; Molla F; De Pizzol M; Regano D; Maione F; Capano S; Locati M; Mantovani A; Latini R; Bussolino F; Giraudo E
J Immunol; 2012 Apr; 188(8):4081-92. PubMed ID: 22442441
[TBL] [Abstract][Full Text] [Related]
8. Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1.
Toyofuku T; Yabuki M; Kamei J; Kamei M; Makino N; Kumanogoh A; Hori M
EMBO J; 2007 Mar; 26(5):1373-84. PubMed ID: 17318185
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor-1 promotes the proliferation and inhibits the apoptosis of pulmonary fibroblasts by Ca(2+) signaling.
Zhang YP; Wang WL; Liu J; Li WB; Bai LL; Yuan YD; Song SX
Thromb Res; 2013 Jan; 131(1):64-71. PubMed ID: 23021499
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of semaphorin as a novel strategy for therapeutic angiogenesis.
Moriya J; Minamino T; Tateno K; Okada S; Uemura A; Shimizu I; Yokoyama M; Nojima A; Okada M; Koga H; Komuro I
Circ Res; 2010 Feb; 106(2):391-8. PubMed ID: 19940264
[TBL] [Abstract][Full Text] [Related]
11. [THE ROLE OF SEMAPHORIN 7A IN SYSTEMIC SCLEROSIS].
Rimar D; Slobodin G; Rosner I; Rozenbaum M; Kaly L; Boulman N; Jiries N; Awisat A; Vadasz Z
Harefuah; 2017 Jul; 156(7):418-421. PubMed ID: 28786275
[TBL] [Abstract][Full Text] [Related]
12. Chronic exposure of interleukin-13 suppress the induction of matrix metalloproteinase-1 by tumour necrosis factor α in normal and scleroderma dermal fibroblasts through protein kinase B/Akt.
Brown Lobbins ML; Shivakumar BR; Postlethwaite AE; Hasty KA
Clin Exp Immunol; 2018 Jan; 191(1):84-95. PubMed ID: 28884475
[TBL] [Abstract][Full Text] [Related]
13. Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis.
Dees C; Tomcik M; Zerr P; Akhmetshina A; Horn A; Palumbo K; Beyer C; Zwerina J; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2011 Jul; 70(7):1304-10. PubMed ID: 21450749
[TBL] [Abstract][Full Text] [Related]
14. Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts.
Bogatkevich GS; Ludwicka-Bradley A; Silver RM
Arthritis Rheum; 2009 Nov; 60(11):3455-64. PubMed ID: 19877031
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic pulmonary fibrosis fibroblasts become resistant to Fas ligand-dependent apoptosis via the alteration of decoy receptor 3.
Im J; Kim K; Hergert P; Nho RS
J Pathol; 2016 Sep; 240(1):25-37. PubMed ID: 27218286
[TBL] [Abstract][Full Text] [Related]
16. A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie's plaques.
Jung KH; Ryu YL; Lee HS; Lee H; Son MK; Yan HH; Hong SW; Ryu JK; Hong S; Suh JK; Hong SS
Int J Oncol; 2013 Jun; 42(6):2001-8. PubMed ID: 23588860
[TBL] [Abstract][Full Text] [Related]
17. Neuroimmune Semaphorin 4A in Cancer Angiogenesis and Inflammation: A Promoter or a Suppressor?
Iyer AS; Chapoval SP
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30598022
[TBL] [Abstract][Full Text] [Related]
18. Semaphorin 4A induces growth cone collapse of hippocampal neurons in a Rho/Rho-kinase-dependent manner.
Yukawa K; Tanaka T; Bai T; Ueyama T; Owada-Makabe K; Tsubota Y; Maeda M; Suzuki K; Kikutani H; Kumanogoh A
Int J Mol Med; 2005 Jul; 16(1):115-8. PubMed ID: 15942687
[TBL] [Abstract][Full Text] [Related]
19. Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts.
Cutolo M; Ruaro B; Montagna P; Brizzolara R; Stratta E; Trombetta AC; Scabini S; Tavilla PP; Parodi A; Corallo C; Giordano N; Paolino S; Pizzorni C; Sulli A; Smith V; Soldano S
Arthritis Res Ther; 2018 May; 20(1):77. PubMed ID: 29720235
[TBL] [Abstract][Full Text] [Related]
20. Thrombin differentiates normal lung fibroblasts to a myofibroblast phenotype via the proteolytically activated receptor-1 and a protein kinase C-dependent pathway.
Bogatkevich GS; Tourkina E; Silver RM; Ludwicka-Bradley A
J Biol Chem; 2001 Nov; 276(48):45184-92. PubMed ID: 11579091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
